<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients (125) who had carotid <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> (<z:hpo ids='HP_0002326'>TIAs</z:hpo>) and one or more accessible carotid lesions visualized angiographically had reconstructive operations of the carotid artery and were then randomly assigned to aspirin or placebo treatment </plain></SENT>
<SENT sid="1" pm="."><plain>The were followed to determine the incidence of subsecquent <z:hpo ids='HP_0002326'>TIAs</z:hpo>, <z:hpo ids='HP_0011420'>death</z:hpo>, <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, or <z:chebi fb="46" ids="15035">retinal</z:chebi> infarction </plain></SENT>
<SENT sid="2" pm="."><plain>Life table analysis (for 24 months follow up) that eliminated <z:hpo ids='HP_0011420'>deaths</z:hpo> which were not <z:hpo ids='HP_0001297'>stroke</z:hpo>-related revealed a significant difference in favor of aspirin </plain></SENT>
<SENT sid="3" pm="."><plain>Because of the small number of patients and the short period of follow up, these results should be interpreted only as consistent with those reported in the initial publication but not conclusive of an aspirin effect in preventing <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>